Ciloxan Ophthalmic Solution
Vision Problems Rising Rapidly in the U.S. »
"Dec. 11, 2012 -- The diabetes and obesity epidemics may be fueling a dramatic rise in the number of people with vision problems, a new study suggests.
Rates of vision problems that can't be treated with glasses or contact lenses, know"...
Read the Vision Problems Rising Rapidly in the U.S. article »
Ciloxan Ophthalmic Solution
INDICATIONS
CILOXAN Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below:
Corneal Ulcers
Serratia marcescens *
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus (Viridans Group) *
Haemophilus influenzae
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus pneumoniae
*Efficacy for this organism was studied in fewer than 10 infections.
DOSAGE AND ADMINISTRATION
Corneal Ulcers: The recommended dosage regimen for the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill two drops in the affected eye hourly. On the third through the fourteenth day, place two drops in the affected eye every four hours. Treatment may be continued after 14 days if corneal re-epithelialization has not occurred.
Bacterial Conjunctivitis: The recommended dosage regimen for the treatment of bacterial conjunctivitis is one or two drops instilled into the conjunctival sac(s) every two hours while awake for two days and one or two drops every four hours while awake for the next five days.
HOW SUPPLIED
As a sterile ophthalmic solution in Alcons DROP-TAINERÃ? dispensing system consisting of a natural low density polyethylene bottle and dispensing plug and tan polypropylene closure. Tamper evidence is provided with a shrink band around the closure and neck area of the package.
2.5 mL in 8 mL bottle - NDC 0065-0656-25
5 mL in 8 mL bottle - NDC 0065-0656-05
10 mL in 10 mL bottle - NDC 0065-0656-10
STORAGE: Store at 2°- 25°C (36°- 77°F). Protect from light.
ANIMAL PHARMACOLOGY
Ciprofloxacin and related drugs have been shown to cause arthropathy in immature animals of most species tested following oral administration. However, a one-month topical ocular study using immature Beagle dogs did not demonstrate any articular lesions.
Rx only
U.S. Patent No. 4,670,444
AlconÃ? Pharmaceuticals
ALCON LABORATORIES, INC. Fort Worth, Texas 76134 USA
Revised: September 2004Ã?2003 Alcon, Inc
FDA revision date:2/07/06
Last reviewed on RxList: 3/28/2006
This monograph has been modified to include the generic and brand name in many instances.
Additional Ciloxan Ophthalmic Solution Information
Ciloxan Ophthalmic Solution - User Reviews
Ciloxan Ophthalmic Solution User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Here is a collection of user reviews for the medication Ciloxan Ophthalmic Solution sorted by most helpful.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Updated & New
